Log In
BCIQ
Print this Print this
 

JM-010

  Manage Alerts
Collapse Summary General Information
Company Bukwang Pharmaceutical Co. Ltd.
DescriptionFixed-dose combination of two undisclosed drugs
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase I
Standard IndicationHyperkinetic movement disorder
Indication DetailsTreat levodopa-induced dyskinesia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/28/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today